IFWM
DFTX

Institute for Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Institute for Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Buy
+46
New +$1.14K ﹤0.01% 1579

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Institute for Wealth Management's DFTX Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 46 shares worth $2.16K. The stake represents ﹤0.01% of the portfolio and ranks #1579 among its holdings.

140 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Institute for Wealth Management held 46 shares of Definium Therapeutics worth $2.16K as of Q2 2026.
  • Definium Therapeutics was a new Institute for Wealth Management position in Q2 2026.
  • Definium Therapeutics made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1579 holding.
  • 140 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.